Impact of Diabetes on the Clinical outcome of COVID 19 Patients admitted in Tertiary Care Hospital of Khyber Pakhtunkhwa, Pakistan
Impact of Diabetes on the Clinical outcome of COVID 19 Patients
DOI:
https://doi.org/10.54393/pjhs.v3i05.225Keywords:
Diabetes Mellitus, COVID-19Abstract
In November 2019, a virus emerged in Wuhan City of China, named as novel coronavirus. Objective: To evaluate the impact of Diabetes on the clinical outcome of COVID 19 patients admitted in Isolation Units at Hayatabad Medical Complex Peshawar. Methods: This was a 6 months’ prospective longitudinal observational study. Diagnosis was made on the basis of positive PCR nasal and / or pharyngeal swabs, following the provisional guidelines of the World Health Organization. Diagnoses of diabetes was confirmed by medical history of the patient. Data regarding socio demographic aspects, comorbidities, hematological and biochemical findings, chest radiographic images, complications, length of stay, treatments and outcomes were collected from the hospital charts. All known Type 2 Diabetics above 40 years of age with positive PCR for COVID 19 infections were included regardless of gender. Type 1 diabetics and those with prior complications were excluded from the study. Results: The ANOVA table showed the overall model was statistically significant predictor ((Duration of diabetes, gender, education and age) of the outcome variable (length of stay in COVID isolation unit) with P value 0.004 reflecting that diabetes has significant impact on the outcome of COVID 19 patients. There was also significant association (chi-square P value .005) between complications developed and HbA1C levels of the admitted patients. Conclusions: Diabetes has significant impact on clinical outcome of Covid 19 patients in terms of complications, length of stay and mortality. The complex nature of both the diseases leaves the patient with high risk of developing complications and mortality.
References
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb; 395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5
Al-Mulla F, Mohammad A, Al Madhoun A, Haddad D, Ali H, Eaaswarkhanth M, et al. ACE2 and FURIN variants are potential predictors of SARS-CoV-2 outcome: A time to implement precision medicine against COVID-19. Heliyon. 2021 Feb; 7(2): e06133. doi: 10.1016/j.heliyon.2021.e06133
Haddad D, John SE, Mohammad A, Hammad MM, Hebbar P, Channanath A, et al. SARS-CoV-2: Proof of recombination between strains and emergence of possibly more virulent ones. MedRxiv. 2020 Jan. doi: 10.1101/2020.11.11.20229765
Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020 May; 20(5):533-534. doi: 10.1016/S1473-3099(20)30120-1
Al-Shammari AA, Ali H, Al-Ahmad B, Al-Refaei FH, Al-Sabah S, Jamal MH, et al. Real-time tracking and forecasting of the COVID-19 outbreak in Kuwait: A mathematical modeling study. MedRxiv. 2020; 2020. doi: 10.1101/2020.05.03.20089771
Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, et al. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA. 2020 Apr; 323(14):1406-1407. doi: 10.1001/jama.2020.2565
Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, et al. SARS-CoV-2 infection in children. New England Journal of Medicine. 2020 Apr; 382(17):1663-5. doi: 10.1056/NEJMc2005073
Williamson E, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients. MedRxiv. 2020 Jan. doi: 10.1101/2020.05.06.20092999
Williams R, Karuranga S, Malanda B, Saeedi P, Basit A, Besançon S, et al. Global and regional estimates and projections of diabetes-related health expenditure: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Research and Clinical Practice. 2020 Apr; 162:108072. doi: 10.1016/j.diabres.2020.108072
Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice. 2010 Jan; 87(1):4-14. doi: 10.1016/j.diabres.2009.10.007
Basit A, Fawwad A, Qureshi H, Shera AS; NDSP Members. Prevalence of diabetes, pre-diabetes and associated risk factors: second National Diabetes Survey of Pakistan (NDSP), 2016-2017. BMJ Open. 2018 Aug; 8(8):e020961. doi: 10.1136/bmjopen-2017-020961
Alahmad B, Al-Shammari AA, Bennakhi A, Al-Mulla F, Ali H. Fasting Blood Glucose and COVID-19 Severity: Nonlinearity Matters. Diabetes Care. 2020 Dec; 43(12):3113-3116. doi: 10.2337/dc20-1941
Yang JK, Feng Y, Yuan MY, Yuan SY, Fu HJ, Wu BY, et al. Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabetic Medicine. 2006 Jun; 23(6):623-8. doi: 10.1111/j.1464-5491.2006.01861.x
Iacobellis G. COVID-19 and diabetes: Can DPP4 inhibition play a role? Diabetes Research and Clinical Practice. 2020 Apr; 162:108125. doi: 10.1016/j.diabres.2020.108125
de Lucena TMC, da Silva Santos AF, de Lima BR, de Albuquerque Borborema ME, de Azevêdo Silva J. Mechanism of inflammatory response in associated comorbidities in COVID-19. Diabetes and Metabolic Syndrome. 2020 Aug; 14(4):597-600. doi: 10.1016/j.dsx.2020.05.025
ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012 Jun; 307(23):2526-33. doi: 10.1001/jama.2012.5669
Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney International. 2005 Jun; 67(6):2089-100. doi: 10.1111/j.1523-1755.2005.00365.x
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar; 323(11):1061-1069. doi: 10.1001/jama.2020.1585
Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. OpenSAFELY: factors associated with COVID-19 death in 17 million patients. Nature. 2020 Aug; 584(7821):430. doi: 10.1038%2Fs41586-020-2521-4
Zhu L, She ZG, Cheng X, Qin JJ, Zhang XJ, Cai J, et al. Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes. Cell Metabolism. 2020 Jun; 31(6):1068-1077.e3. doi: 10.1016/j.cmet.2020.04.021
Marfella R, Paolisso P, Sardu C, Bergamaschi L, D'Angelo EC, Barbieri M, et al. Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients. Diabetes and Metabolism. 2020 Oct; 46(5):403-405. doi: 10.1016/j.diabet.2020.05.005
Chen X, Hu W, Ling J, Mo P, Zhang Y, Jiang Q, et al. Hypertension and diabetes delay the viral clearance in COVID-19 patients. MedRxiv. 2020 Jan. doi: 10.1101/2020.03.22.20040774
Shi Q, Zhang X, Jiang F, Zhang X, Hu N, Bimu C, et al. Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study. Diabetes Care. 2020 Jul; 43(7):1382-1391. doi: 10.2337/dc20-0598
Donath MY and Shoelson SE. Type 2 diabetes as an inflammatory disease. Nature reviews immunology. 2011 Feb; 11(2):98-107. doi: https://doi.org/10.1038/nri2925
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Pakistan Journal of Health Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments
